Deep Track Capital, LP
Filing Date
Global Rank
#921
/ 7,976
▲ 41
Top Industry
Biotechnology
88.4%
3Y Alpha vs SPY
+3.6%
Period ended 9 months ago
Filed Nov 14, 2025 · 7mo
16 quarters · since Dec 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+93.6%
SPY
+76.5%
Annualised alpha
+3.8%
Max drawdown
−50.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
50 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
8.6%
+0.1 pts
Top 5
36.4%
+1.0 pts
Top 10
57.6%
+0.5 pts
HHI
448
Diversified+24
Portfolio Trend
16 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 98.2% | $2,979,116,649 |
| Unclassified | 1.8% | $54,710,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
10 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | +1,250,000 | 3,000,000 | $178,290,000 | |
| APLS | Apellis Pharmaceuticals, Inc. | +1,000,382 | 8,000,382 | $181,048,644 | |
| MBX | MBX Biosciences, Inc. | +961,408 | 3,150,000 | $55,125,000 | |
| PCVX | Vaxcyte, Inc. | +850,000 | 3,000,000 | $108,060,000 | |
| ORKA | Oruka Therapeutics, Inc. | +735,983 | 2,654,781 | $51,051,438 | |
| CYTK | Cytokinetics Inc | +650,000 | 4,300,000 | $236,328,000 | |
| BBIO | BridgeBio Pharma, Inc. | +300,000 | 1,200,000 | $62,328,000 | |
| IMVT | Immunovant, Inc. | +228,845 | 9,728,845 | $156,828,981 | |
| AXSM | Axsome Therapeutics, Inc. | +98,629 | 900,000 | $109,305,000 | |
| OLMA | Olema Pharmaceuticals, Inc. | +27,339 | 3,470,172 | $33,972,983 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
18 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AUTL | Autolus Therapeutics plc | −14,283,534 | 2,568,613 | $4,186,839 | |
| OCUL | Ocular Therapeutix, Inc | −2,362,283 | 11,932,137 | $139,486,681 | |
| ENGN | enGene Therapeutics Inc. | −2,318,222 | 2,239,353 | $15,294,780 | |
| GERN | Geron Corp | −1,903,478 | 41,096,522 | $56,302,235 | |
| PTGX | Protagonist Therapeutics, Inc | −1,530,208 | 1,715,691 | $113,973,353 | |
| ZURA | Zura Bio Ltd | −1,468,548 | 259,014 | $1,121,530 | |
| IONS | Ionis Pharmaceuticals Inc | −1,083,400 | 3,808,144 | $249,128,780 | |
| CMPS | COMPASS Pathways plc | −971,359 | 7,859,648 | $45,035,783 | |
| GPCR | Structure Therapeutics Inc. | −918,106 | 4,215,811 | $118,042,708 | |
| GHRS | GH Research PLC | −750,000 | 1,250,000 | $17,875,000 | |
| CLYM | Climb Bio, Inc. | −530,326 | 509,789 | $1,024,675 | |
| HELP | Cybin Inc. | −529,987 | 1,000,000 | $5,890,000 | |
| AVTX | Avalo Therapeutics, Inc. | −422,503 | 144,600 | $1,837,866 | |
| ANIP | Ani Pharmaceuticals Inc | −250,000 | 450,000 | $41,220,000 | |
| JBIO | Jade Biosciences, Inc. | −229,409 | 2,279,892 | $19,675,467 | |
| XENE | Xenon Pharmaceuticals Inc. | −150,000 | 1,200,000 | $48,180,000 | |
| GH | Guardant Health, Inc. | −95,914 | 4,154,086 | $259,547,293 | |
| NRIX | Nurix Therapeutics, Inc. | −7,886 | 6,057,024 | $55,966,901 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
12 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| EXAS | EXACT SCIENCES CORP | 1,000,000 | $54,710,000 | |
| LBRX | Lb Pharmaceuticals Inc | 3,352,804 | $52,940,775 | |
| QURE | uniQure N.V. | 483,092 | $28,198,080 | |
| DYN | Dyne Therapeutics, Inc. | 2,000,000 | $25,300,000 | |
| GMAB | Genmab A/S | 481,267 | $14,760,458 | |
| TNGX | Tango Therapeutics, Inc. | 1,454,562 | $12,218,320 | |
| IMA | ImageneBio, Inc. | 878,516 | $7,159,905 | |
| CRMD | CorMedix Inc. | 500,000 | $5,815,000 | |
| PEPG | PepGen Inc. | 1,200,000 | $5,544,000 | |
| XFOR | X4 Pharmaceuticals, Inc | 1,122,484 | $3,838,895 | |
| ACAD | Acadia Pharmaceuticals Inc | 105,085 | $2,242,513 | |
| BMRN | Biomarin Pharmaceutical Inc | 24,856 | $1,346,200 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
18 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| INSM | INSMED Inc | 1,750,000 | $176,120,000 | |
| RARE | Ultragenyx Pharmaceutical Inc. | 1,350,000 | $49,086,000 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 2,233,148 | $41,603,547 | |
| TECX | Tectonic Therapeutic, Inc. | 1,401,938 | $27,856,508 | |
| ABVX | Abivax S.A. | 3,480,144 | $26,623,101 | |
| UPB | Upstream Bio, Inc. | 1,442,767 | $15,841,581 | |
| SRPT | Sarepta Therapeutics, Inc. | 709,800 | $12,137,580 | |
| BCYC | Bicycle Therapeutics PLC | 1,203,244 | $8,362,545 | |
| CNTA | Centessa Pharmaceuticals plc | 500,000 | $6,570,000 | |
| NVAX | Novavax Inc | 998,542 | $6,290,814 | |
| IVVD | Invivyd, Inc. | 8,585,980 | $6,138,975 | |
| PLRX | Pliant Therapeutics, Inc. | 3,947,807 | $4,579,456 | |
| INO | Inovio Pharmaceuticals, Inc. | 1,981,370 | $4,041,994 | |
| KRRO | Korro Bio, Inc. | 277,966 | $3,471,795 | |
| SYRE | Spyre Therapeutics, Inc. | 219,015 | $3,278,654 | |
| SEPN | Septerna, Inc. | 121,716 | $1,286,538 | |
| RAPP | Rapport Therapeutics, Inc. | 98,237 | $1,116,954 | |
| OKUR | OnKure Therapeutics, Inc. | 180,510 | $431,418 | |
| No positions match the current search. | ||||
50 positions ·
$3,033,826,649 total
· as of Sep 30, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| GH |
Guardant Health, Inc.
Healthcare
|
Reduced | 4,154,086 | $259,547,293 | 8.56% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Reduced | 3,808,144 | $249,128,780 | 8.21% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Added | 4,300,000 | $236,328,000 | 7.79% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Added | 8,000,382 | $181,048,644 | 5.97% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Added | 3,000,000 | $178,290,000 | 5.88% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Added | 9,728,845 | $156,828,981 | 5.17% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Reduced | 11,932,137 | $139,486,681 | 4.60% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Reduced | 4,215,811 | $118,042,708 | 3.89% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Held | 5,380,449 | $116,110,089 | 3.83% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Reduced | 1,715,691 | $113,973,353 | 3.76% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 900,000 | $109,305,000 | 3.60% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 3,000,000 | $108,060,000 | 3.56% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Held | 3,948,910 | $102,395,236 | 3.38% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Held | 1,800,000 | $65,394,000 | 2.16% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 1,200,000 | $62,328,000 | 2.05% | |
| GERN |
Geron Corp
Healthcare
|
Reduced | 41,096,522 | $56,302,235 | 1.86% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Held | 7,495,000 | $56,287,450 | 1.86% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Reduced | 6,057,024 | $55,966,901 | 1.84% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Added | 3,150,000 | $55,125,000 | 1.82% | |
| EXAS |
EXACT SCIENCES CORP
|
NEW | 1,000,000 | $54,710,000 | 1.80% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
NEW | 3,352,804 | $52,940,775 | 1.75% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Held | 2,000,000 | $51,740,000 | 1.71% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Added | 2,654,781 | $51,051,438 | 1.68% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 1,200,000 | $48,180,000 | 1.59% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Reduced | 7,859,648 | $45,035,783 | 1.48% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
Reduced | 450,000 | $41,220,000 | 1.36% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Held | 2,426,657 | $38,316,914 | 1.26% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Added | 3,470,172 | $33,972,983 | 1.12% | |
| QURE |
uniQure N.V.
Healthcare
|
NEW | 483,092 | $28,198,080 | 0.93% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
NEW | 2,000,000 | $25,300,000 | 0.83% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Reduced | 2,279,892 | $19,675,467 | 0.65% | |
| GHRS |
GH Research PLC
Healthcare
|
Reduced | 1,250,000 | $17,875,000 | 0.59% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Reduced | 2,239,353 | $15,294,780 | 0.50% | |
| GMAB |
Genmab A/S
Healthcare
|
NEW | 481,267 | $14,760,458 | 0.49% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
NEW | 1,454,562 | $12,218,320 | 0.40% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
Held | 7,419,355 | $7,189,354 | 0.24% | |
| IMA |
ImageneBio, Inc.
Healthcare
|
NEW | 878,516 | $7,159,905 | 0.24% | |
| XNCR |
Xencor Inc
Healthcare
|
Held | 549,439 | $6,444,919 | 0.21% | |
| HELP |
Cybin Inc.
Healthcare
|
Reduced | 1,000,000 | $5,890,000 | 0.19% | |
| CRMD |
CorMedix Inc.
Healthcare
|
NEW | 500,000 | $5,815,000 | 0.19% | |
| PEPG |
PepGen Inc.
Healthcare
|
NEW | 1,200,000 | $5,544,000 | 0.18% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Held | 453,686 | $5,394,326 | 0.18% | |
| ALGS |
Aligos Therapeutics, Inc.
Healthcare
|
Held | 444,110 | $4,352,278 | 0.14% | |
| AUTL |
Autolus Therapeutics plc
Healthcare
|
Reduced | 2,568,613 | $4,186,839 | 0.14% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
NEW | 1,122,484 | $3,838,895 | 0.13% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
NEW | 105,085 | $2,242,513 | 0.07% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Reduced | 144,600 | $1,837,866 | 0.06% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
NEW | 24,856 | $1,346,200 | 0.04% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Reduced | 259,014 | $1,121,530 | 0.04% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
Reduced | 509,789 | $1,024,675 | 0.03% |